Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com
|
|
|
51-200 employees
View all Acceleron Pharma employees
|
|
Biotechnology
|
|
$10M–$50M
|
|
(617) 649-9200
|
|
128 Sidney Street, Cambridge, MA 02139, US
|
|
2003
|
|
Biopharmaceuticals, Rare Diseases, Orphan Disease Therapeutics, Serious Diseases
|
Arslan Gokhan is the CEO of Acceleron Pharma. To contact Arslan Gokhan email at [email protected].
The decision makers in Acceleron Pharma are Amelia Pearsall, Arslan Gokhan, Chet Tetta, etc. Click to Find Acceleron Pharma decision makers emails.
Acceleron Pharma headquarters is located at 128 Sidney Street, Cambridge, MA 02139, US.
Acceleron Pharma generates an estimated $10M–$50M annually, based on industry analysis and publicly available market data.
You can contact Acceleron Pharma by calling (617) 649-9200.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.